Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Clinical trial NCT00914771 · COMPLETED

Trial details

NCT number: NCT00914771
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pandemic H5N1 Influenza

Start date: 2009-09-01
Primary completion: 2009-12-01
Enrollment: 722

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.